In the following we evaluate differences in expression between therapy-naive tumors compared to the normal tissue and to neoadjuvant pretreated tumors (NACT): As already indicated, CTLA-4 expression is 3.5–4fold increased in esophageal tumor specimen compared to normal tissue (Fig. 1c). Here, CTLA4 is linked to neoplasm of esophagus.